Vanderbilt University Medical Center (VUMC)


 

ESMO 2024 Insights: Final Analysis of the Phase 3 LITESPARK-005 Study of Belzutifan vs. Everolimus in Patients With Previously Treated Advanced ccRCC

95 views
September 25, 2024
Comments 0
Login to view comments. Click here to Login